NCT07489833尚未招募不适用
The Exploration of the Relationship Between Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue in Patients With Colorectal Cancer
Chang Gung Memorial Hospital0 个研究点目标入组 80 人开始时间: 2026年4月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 主要终点
- Self-report Questionnaire
研究概览
简要总结
The aim of this study is to integrate insights from metabolomics and TCMBC to identify biomarkers and physiological pathways associated with CRF.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •(1) patients aged 18 years or older, (2) diagnosed with stage I to III CRC and scheduled for surgical treatment, (3) cognitively intact and able to communicate in either Mandarin or Taiwanese, and (4) willing to participate in the study and provide written informed consent.
排除标准
- •(1) patients diagnosed with stage IV colorectal cancer, and (2) patients with recurrent colorectal cancer or other concurrent cancers.
结局指标
主要结局
Self-report Questionnaire
时间窗: Change from baseline to 3 months after surgery.
The structure includes the Fatigue Symptom Inventory, and the Body Constitution Questionnaire
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker: A Controlled Clinical TrialPulpitisNCT07452614Abeer Ghalib Abdul-khaliq55
尚未招募
不适用
Metabolic Syndrome-Associated Periodontal Inflammatory Surface AreaNCT07354815Recep Tayyip Erdogan University Training and Research Hospital100
尚未招募
不适用
Study of body signals and bedside scan to track recovery in severe lung failureCTRI/2025/07/090794Ms Ashritha A Udupa224
已完成
不适用
Determination of Metabolomic Profile Differences in Possible Sarcopenia Accompanying Fibromyalgia Syndrome in WomenFibromyalgiaNCT07381348Ankara City Hospital Bilkent66
尚未招募
不适用
Testing the potential use of using a new biomarker found in the blood of children suffering from blood cancer to predict the severity and outcome of their disease.CTRI/2024/01/061909Other60
